Fuel livesaving advancments, all year round! Give Now

Close Icon

An Evening of Partnership and Discovery

Wednesday, April 17, 2024

5:30 – 7:30 p.m.

San Francisco, CA 94105

Register Now

At An Evening of Partnership and Discovery, you will hear from Dr. Paul Klotman, Baylor College of Medicine president, CEO and executive dean, and Dr. Joseph Petrosino, Baylor’s chief scientific innovation officer and one of its most prominent thought-leaders, about how the technology transfer process works, the stages of development and what’s on the horizon for Baylor College of Medicine Ventures. Drs. Trey Westbrook, Maksim Mamonkin and Anthony Maresso will share their experiences, the pivotal role of philanthropy in their successful endeavors and what the future has in store. 

About the Event

To improve lives around the world, biomedical innovation must emerge from the lab and be placed in the hands of medical professionals treating patients.  

As the journey from the lab to the bedside continues to shift, and as medical and pharmaceutical giants look to expand their development partnerships, leading academic medical centers are bolstering their research initiatives and seizing the opportunity to assume a crucial role in improving healthcare. 

Baylor College of Medicine Ventures (BCMV) has successfully positioned itself as a partner-of-choice for industry players looking to navigate this journey, advancing exciting collaborations between Baylor and various commercial partners. BCMV supports, cultivates and accelerates translational research by fostering discovery, retaining promising young faculty and securing strategic support, especially in the form of philanthropy.  

Philanthropic support for early-stage concepts empowers visionary donors to partner with the College in evaluating potential candidates for seed funding, providing crucial resourceswhen other entities will not. Philanthropy also opens new opportunities for traditional investment in companies launched through Baylor’s commercialization activities, affording forward-thinking donors the chance to become first-round investors in the production of healthcare and biomedical sciences breakthroughs. 

Access the Event’s Pre-Reads

About the Speakers

president dr paul klotman
Paul Klotman, M.D.

President, CEO and Executive Dean 
Baylor College of Medicine 

Amanda Burkardt, M.I.T., M.B.A., M.Sc.

CEO 
PHIOGEN INC. 

Maksim Mamonkin, Ph.D.

Associate Professor, Department of Pathology & Immunology and the Center for Cell and Gene Therapy  
Baylor College of Medicine  
Chief Scientific Officer  
March Biosciences  

Anthony Maresso, Ph.D.

Joseph Melnick Endowed Chair of Virology and Microbiology
Professor, Department of Molecular Virology and Microbiology
Baylor College of Medicine  
Co-Founder   
PHIOGEN INC.

Joseph F. Petrosino, Ph.D. 

Chief Scientific Innovation Officer  
Kyle and Josephine Morrow Chair in Molecular Virology and Microbiology
Professor and Chair, Department of Molecular Virology and Microbiology  
Director, Alkek Center for Metagenomics and Microbiome Research  
Baylor College of Medicine  

Trey Westbrook, Ph.D.

Executive Director
Therapeutic Innovation Center (THINC)
Robert A. Welch Chair in Chemistry
McNair Scholar in Cancer Research
Professor, Deptartment of Molecular & Human Genetics
Baylor College of Medicine
Co-founder, Marlinspike Therapeutics

About BCMV

Baylor College of Medicine Ventures fosters a culture of commercialization by engaging university innovators, entrepreneurs and industry to fully develop ideas and identify market opportunities or collaborative ventures for the benefit of society. 

Our team of commercial experts cultivate ideas, connect people, drive technology management, and elevate business engagement. We also partner with philanthropic advisors to engage support at critical points and increase the chances for breakthroughs by developing and de-risking commercial targets.